Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Gentile

Showing results (211-220 of 313) with videos related to

Pageof 32
Sort By:
Plos One|June 26, 2015
Flow Cytometric Immunobead Assay for Detection of BCR-ABL1 Fusion Proteins in Chronic Myleoid Leukemia: Comparison with FISH and PCR TechniquesAnna Grazia Recchia, Nadia Caruso, Sabrina Bossio, et al.
Plos One|September 8, 2011
Relevance of stereotyped B-cell receptors in the context of the molecular, cytogenetic and clinical features of chronic lymphocytic leukemiaFrancesco Maura, Giovanna Cutrona, Sonia Fabris, et al.
Haematologica|May 22, 2025
Mitochondrial fission factor drives an actionable metabolic vulnerability in multiple myelomaMaria Eugenia Gallo Cantafio, Ilenia Valentino, Roberta Torcasio, et al.
Hematological Oncology|August 6, 2022
Lack of efficacy of convalescent plasma in COVID-19 patients with concomitant hematological malignancies: An Italian retrospective studyFrancesco Lanza, Federica Monaco, Fabio Ciceri, et al.
Leukemia Research|June 4, 2015
Surrogate molecular markers for IGHV mutational status in chronic lymphocytic leukemia for predicting time to first treatmentFortunato Morabito, Giovanna Cutrona, Laura Mosca, et al.
European Journal of Haematology|April 24, 2026
Regional Standardization of CLL Management: Results of a Delphi Consensus ProcessEnrica Antonia Martino, Annalisa Chiarenza, Salvatrice Mancuso, et al.
Expert Opinion on Investigational Drugs|June 20, 2020
TP53 dysfunction in chronic lymphocytic leukemia: clinical relevance in the era of B-cell receptors and BCL-2 inhibitorsFortunato Morabito, Massimo Gentile, Paola Monti, et al.
European Journal of Haematology|November 26, 2009
Safety and efficacy of bortezomib-based regimens for multiple myeloma patients with renal impairment: a retrospective study of Italian Myeloma Network GIMEMAFortunato Morabito, Massimo Gentile, Stefania Ciolli, et al.
British Journal of Haematology|March 4, 2014
High-throughput sequencing for the identification of NOTCH1 mutations in early stage chronic lymphocytic leukaemia: biological and clinical implicationsMarta Lionetti, Sonia Fabris, Giovanna Cutrona, et al.
Clinical Immunology (Orlando, Fla.)|July 20, 2016
A non-invasive approach to monitor chronic lymphocytic leukemia engraftment in a xenograft mouse model using ultra-small superparamagnetic iron oxide-magnetic resonance imaging (USPIO-MRI)Francesca Valdora, Giovanna Cutrona, Serena Matis, et al.
Pageof 32

Showing results (211-220 of 313) with videos related to

Sort By:
Pageof 32
Plos One|June 26, 2015
Flow Cytometric Immunobead Assay for Detection of BCR-ABL1 Fusion Proteins in Chronic Myleoid Leukemia: Comparison with FISH and PCR TechniquesAnna Grazia Recchia, Nadia Caruso, Sabrina Bossio, et al.
Plos One|September 8, 2011
Relevance of stereotyped B-cell receptors in the context of the molecular, cytogenetic and clinical features of chronic lymphocytic leukemiaFrancesco Maura, Giovanna Cutrona, Sonia Fabris, et al.
Haematologica|May 22, 2025
Mitochondrial fission factor drives an actionable metabolic vulnerability in multiple myelomaMaria Eugenia Gallo Cantafio, Ilenia Valentino, Roberta Torcasio, et al.
Hematological Oncology|August 6, 2022
Lack of efficacy of convalescent plasma in COVID-19 patients with concomitant hematological malignancies: An Italian retrospective studyFrancesco Lanza, Federica Monaco, Fabio Ciceri, et al.
Leukemia Research|June 4, 2015
Surrogate molecular markers for IGHV mutational status in chronic lymphocytic leukemia for predicting time to first treatmentFortunato Morabito, Giovanna Cutrona, Laura Mosca, et al.
European Journal of Haematology|April 24, 2026
Regional Standardization of CLL Management: Results of a Delphi Consensus ProcessEnrica Antonia Martino, Annalisa Chiarenza, Salvatrice Mancuso, et al.
Expert Opinion on Investigational Drugs|June 20, 2020
TP53 dysfunction in chronic lymphocytic leukemia: clinical relevance in the era of B-cell receptors and BCL-2 inhibitorsFortunato Morabito, Massimo Gentile, Paola Monti, et al.
European Journal of Haematology|November 26, 2009
Safety and efficacy of bortezomib-based regimens for multiple myeloma patients with renal impairment: a retrospective study of Italian Myeloma Network GIMEMAFortunato Morabito, Massimo Gentile, Stefania Ciolli, et al.
British Journal of Haematology|March 4, 2014
High-throughput sequencing for the identification of NOTCH1 mutations in early stage chronic lymphocytic leukaemia: biological and clinical implicationsMarta Lionetti, Sonia Fabris, Giovanna Cutrona, et al.
Clinical Immunology (Orlando, Fla.)|July 20, 2016
A non-invasive approach to monitor chronic lymphocytic leukemia engraftment in a xenograft mouse model using ultra-small superparamagnetic iron oxide-magnetic resonance imaging (USPIO-MRI)Francesca Valdora, Giovanna Cutrona, Serena Matis, et al.
Pageof 32